Novaes 2012a.
Study characteristics | |||
Patient Sampling | Method of sampling: selected Included conditions: unclear Teeth: primary molars ‐ "recently extracted primary molars were selected" Sealants: unclear Surface: occlusal |
||
Patient characteristics and setting | Age: not reported Sex: not reported Ethnicity: not reported Country: Sao Paulo, Brazil Setting: extracted teeth Number of participants/teeth/sites: 77 teeth/113 sites Prevalence: enamel 0.57, dentine 0.17 |
||
Index tests | Category of test: DIAGNOdent, DIAGNOdentpen and VistaProof Sequence of test(s): index tests (radiograph,visual, DIAGNOdent, VistaProof) then reference standard Examiner training and calibration: trained but no calibration Teeth cleaning prior to examination: yes Tooth drying prior to examination: yes Threshold applied: calculated in study: DIAGNOdent: 0–7 sound, 8‐23 enamel, 24+ dentine DIAGNOdentpen: 0‐8 sound, 9‐30 enamel, 31+ dentine VistaProof: "numerical value from 0 to 3 corresponding to the lesion severity is assigned" Device specifics: tip A |
||
Target condition and reference standard(s) | Category: histology Sequence of index test and reference standard: index test then reference standard Training of examiner: not reported Blinding to index test: yes Multiple tests: no Site selection: sectioned teeth Target condition: sound, outer half of enamel, inner half of enamel, outer half of dentine, deep dentine |
||
Flow and timing | Participants with index test but no reference standard: 0 Participants with reference standard but no index test: 0 Time interval between tests: 1 week to allow for separation of teeth Participants receiving both tests but excluded from results: 0 |
||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
If multiple tests were applied were different examiners used for each (in vivo)? | Unclear | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (Green fluorescence) | |||
DOMAIN 2: Index Test (Blue fluorescence) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
If multiple tests were applied were different examiners used for each (in vivo)? | Unclear | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (Red fluorescence) | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |